CytomX Therapeutics, Inc.

Q1 2017 13F Holders

Symbol
CTMX
CUSIP
23284F105
Type
Equity
Class
COM
Num filers
87
Total reported value, excl. options
$332M
Manager Report Date Value ($000) Shares Option Type